Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference61 articles.
1. The first component of human complement (C1): activation and control;Ziccardi;Springer Semin Immunopathol,1983
2. Complement regulators and inhibitory proteins;Zipfel;Nat Rev Immunol,2009
3. T-cell regulation: with complements from innate immunity;Kemper;Nat Rev Immunol,2007
4. Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody;Bologna;J Immunol,2011
5. Function and heterogeneity of human fc receptors for immunoglobulin G;Unkeless;J Clin Invest,1989
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system;Frontiers in Immunology;2023-11-23
2. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma;Frontiers in Genetics;2022-04-26
3. Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs;Cancers;2021-05-20
4. Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen;mAbs;2019-12-12
5. Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections;Vaccines;2019-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3